Fernandez-Martinez A, Krop IE, Hillman DW, Polley MY, et al. Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer. J Clin Oncol 2020 Oct 23:JCO2001276. doi: 10.1200/JCO.20.01276.
PMID: 33095682